ad image

iPSC

1 / 1
Scaling Cell and Gene Therapy Processes from R&D to Production
Cell and Gene Therapy

Scaling Cell and Gene Therapy Processes from R&D to Production

Shawn Bates; Antonio Fernandez-Perez, Ph.D.

Corning Life Sciences

PAO-12-23-CL-03Dec 12, 2023
Umoja Biopharma
CAR-T and iPSC Platform Technologies

Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting

Umoja Biopharma

PR-M11-22-06Nov 11, 2022
CCRM
iPSCs

Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies

CCRM

PR-M11-22-04Nov 07, 2022
Pluristyx
M&A

Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement

Pluristyx

PR-M10-22-04Oct 06, 2022
FUJIFILM
Strategic Alliance

FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process

FUJIFILM

PR-M01-22-05Jan 06, 2022
Curi Bio
Stem Cells

Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms

Curi Bio

PR-M03-21-004-1062Mar 18, 2021
iPSCs: Moving from Drug Testing to Novel Cell Therapies
Stem Cells

iPSCs: Moving from Drug Testing to Novel Cell Therapies

Cenk Sumen, Ph.D.

MaxCyte

PAP-Q3-19-CL-030Oct 28, 2019
1 / 1